Skip to main content

Acura Pharmaceuticals Inc (NASDAQ: ACUR) Investor Securities Class Action Lawsuit 09/10/2010

  • If you purchased shares of Acura Pharmaceuticals Inc (NASDAQ: ACUR), you might have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 14, 2012 - The court approved the settlement, entered the orders approving the plan of allocation, the motion for attorneys’ fees and expenses, and dismissed the action with prejudice. February 16, 2012 - The court held a final settlement hearing. November 10, 2011 - The court preliminarily approved the settlement. October 31, 2011 - Parties filed a stipulation of settlement....



You must register (for free) or login to view the entire case.